skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,279  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Material Type:
Article
Add to My Research

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Journal of clinical oncology, 2023-01, Vol.41 (3), p.528-540 [Peer Reviewed Journal]

2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.22.00343 ;PMID: 35998300

Full text available

2
SnapShot: Cancer Immunotherapy with Oncolytic Viruses
Material Type:
Article
Add to My Research

SnapShot: Cancer Immunotherapy with Oncolytic Viruses

Cell, 2019-02, Vol.176 (5), p.1240-1240.e1 [Peer Reviewed Journal]

2019 ;Copyright © 2019. Published by Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2019.01.051 ;PMID: 30794777

Full text available

3
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Material Type:
Article
Add to My Research

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Journal of clinical oncology, 2018-05, Vol.36 (14), p.1419-1427 [Peer Reviewed Journal]

2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.8219 ;PMID: 29432077

Full text available

4
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Material Type:
Article
Add to My Research

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Cancer cell, 2020-10, Vol.38 (4), p.454-472 [Peer Reviewed Journal]

2020 ;Published by Elsevier Inc. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2020.07.013 ;PMID: 32822573

Full text available

5
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Material Type:
Article
Add to My Research

Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2619-2626 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.67.1529 ;PMID: 27298410

Full text available

6
Optimizing oncolytic virotherapy in cancer treatment
Material Type:
Article
Add to My Research

Optimizing oncolytic virotherapy in cancer treatment

Nature reviews. Drug discovery, 2019-09, Vol.18 (9), p.689-706 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2019 ;Springer Nature Limited 2019. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0029-0 ;PMID: 31292532

Full text available

7
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Material Type:
Article
Add to My Research

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Nature reviews. Clinical oncology, 2021-09, Vol.18 (9), p.558-576 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-021-00507-y ;PMID: 34006998

Full text available

8
Oncolytic virus therapy: A new era of cancer treatment at dawn
Material Type:
Article
Add to My Research

Oncolytic virus therapy: A new era of cancer treatment at dawn

Cancer science, 2016-10, Vol.107 (10), p.1373-1379 [Peer Reviewed Journal]

2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.13027 ;PMID: 27486853

Full text available

9
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
Material Type:
Article
Add to My Research

Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy

Clinical cancer research, 2016-03, Vol.22 (5), p.1048-1054 [Peer Reviewed Journal]

2015 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-15-2667 ;PMID: 26719429

Full text available

10
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
Material Type:
Article
Add to My Research

An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13), p.3635-3648 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-21-0035 ;PMID: 34006525

Full text available

11
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors
Material Type:
Article
Add to My Research

Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.5195-5205 [Peer Reviewed Journal]

2014 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-14-0697 ;PMID: 25060519

Full text available

12
Immunotherapy for hepatocellular carcinoma: Current and future
Material Type:
Article
Add to My Research

Immunotherapy for hepatocellular carcinoma: Current and future

World journal of gastroenterology : WJG, 2019-06, Vol.25 (24), p.2977-2989

The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. 2019 ;ISSN: 1007-9327 ;EISSN: 2219-2840 ;DOI: 10.3748/wjg.v25.i24.2977 ;PMID: 31293335

Full text available

13
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies
Material Type:
Article
Add to My Research

Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies

Nature reviews. Clinical oncology, 2020-01, Vol.17 (1), p.49-64 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2020 ;ISSN: 1759-4774 ;ISSN: 1759-4782 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-019-0272-7 ;PMID: 31595049

Full text available

14
Intratumoral Immunotherapy: From Trial Design to Clinical Practice
Material Type:
Article
Add to My Research

Intratumoral Immunotherapy: From Trial Design to Clinical Practice

Clinical cancer research, 2021-02, Vol.27 (3), p.665-679 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-0473 ;PMID: 32943460

Full text available

15
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Material Type:
Article
Add to My Research

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

The New England journal of medicine, 2022-06, Vol.386 (26), p.2471-2481 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2202028 ;PMID: 35767439

Full text available

16
Cancer immunotherapy comes of age and looks for maturity
Material Type:
Article
Add to My Research

Cancer immunotherapy comes of age and looks for maturity

Nature communications, 2020-07, Vol.11 (1), p.3325-3325, Article 3325 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-17140-5 ;PMID: 32620755

Full text available

17
Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
Material Type:
Article
Add to My Research

Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer

Frontiers in immunology, 2018-04, Vol.9, p.866-866 [Peer Reviewed Journal]

Copyright © 2018 Marelli, Howells, Lemoine and Wang. 2018 Marelli, Howells, Lemoine and Wang ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2018.00866 ;PMID: 29755464

Full text available

18
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Material Type:
Article
Add to My Research

Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones

Molecular therapy, 2018-06, Vol.26 (6), p.1414-1422 [Peer Reviewed Journal]

2018 The American Society of Gene and Cell Therapy ;Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2018. The American Society of Gene and Cell Therapy ;2018 The American Society of Gene and Cell Therapy. 2018 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2018.04.001 ;PMID: 29703699

Full text available

19
Talimogene laherparepvec: First in class oncolytic virotherapy
Material Type:
Article
Add to My Research

Talimogene laherparepvec: First in class oncolytic virotherapy

Human vaccines & immunotherapeutics, 2018-04, Vol.14 (4), p.839-846 [Peer Reviewed Journal]

2018 The Author(s). Published with license by Taylor & Francis 2018 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2017.1412896 ;PMID: 29420123

Full text available

20
NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
Material Type:
Article
Add to My Research

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy

Clinical cancer research, 2022-04, Vol.28 (7), p.1460-1473 [Peer Reviewed Journal]

2022 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-2347 ;PMID: 35022322

Full text available

Results 1 - 20 of 1,279  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,190)

Refine My Results

Creation Date 

From To
  1. Before 2007  (66)
  2. 2007 To 2010  (299)
  3. 2011 To 2014  (323)
  4. 2015 To 2019  (351)
  5. After 2019  (241)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,278)
  2. Book Chapters  (1)
  3. More options open sub menu

Language 

  1. English  (1,272)
  2. Japanese  (260)
  3. French  (5)
  4. German  (2)
  5. Russian  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait